Generic substitution of lamotrigine among medicaid patients with diverse indications: a cohort-crossover study. - Wikidata - wikimedia - TriplyDB

Generic substitution of lamotrigine among medicaid patients with diverse indications: a cohort-crossover study.

Generic substitution of lamotrigine among medicaid patients with diverse indications: a cohort-crossover study.

http://www.wikidata.org/entity/Q36916999

about

Lamotrigine add-on for drug-resistant partial epilepsy Causal inference as an emerging statistical approach in neurology: an example for epilepsy in the elderly.Real-life effectiveness and safety of the inhalation suspension budesonide comparator vs the originator product for the treatment of patients with asthma: a historical cohort study using a US health claims database Distribution and trends in outpatient utilization of generic versus brand name psychopharmaceuticals during a ten-year period in Croatia.Rational use of generic psychotropic drugs.Factors associated with seizure recurrence in epilepsy patients treated with antiepileptic monotherapy: A retrospective observational cohort study using US administrative insurance claims.The Impact of Generic Substitution on Health and Economic Outcomes: A Systematic Review.Safety of switching from brand-name to generic levetiracetam in patients with epilepsy.Comparison of Generic-to-Brand Switchback Rates Between Generic and Authorized Generic Drugs.Brand name to generic substitution of antiepileptic drugs does not lead to seizure-related hospitalization: a population-based case-crossover study.

P2860

Q26471446-C7122B66-F6D4-4F02-BF7D-A9ED596DD6A2 Q30238821-6865ABF7-5C87-4A3E-803F-A211CA9A8DDB Q33719253-4F25A452-D1DE-488F-B04F-FBC5AFC9135F Q34669292-07125887-BCC7-48A6-9426-F96DA6229117 Q34688387-733BD5A5-0005-428F-861A-3D2247018044 Q38236299-C7563292-ABE2-4B3E-8509-DC2420E840BE Q38532357-99EFA02C-D840-45B7-8F29-0259306D6490 Q38621374-CB77EC47-F2AE-4A0A-B9B2-54DDA27BABD9 Q38984059-C8440643-5DCB-40F3-A320-9FD3D2E60C39 Q40512938-8060CFC0-9542-4424-9E50-AF5BA7D2D998

P2860

Generic substitution of lamotrigine among medicaid patients with diverse indications: a cohort-crossover study.

http://www.wikidata.org/entity/Q36916999

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Generic substitution of lamotr ...... ons: a cohort-crossover study.

@en

type

label

Generic substitution of lamotr ...... ons: a cohort-crossover study.

@en

prefLabel

Generic substitution of lamotr ...... ons: a cohort-crossover study.

@en

P1433

Q36916999-06EB33EA-0CCC-46C3-AE6B-234F8F020E54

P1476

Q36916999-887B4E72-593B-48E7-96DE-9FD7EAD7571C

P2093

Q36916999-715656E2-206E-4FE6-B639-E8D8320EA40E

Q36916999-851DDA6F-090C-446C-A966-B18A8107D75A

Q36916999-BE53A60D-F904-42B0-AA2C-1A754E55C2B2

Q36916999-DAC106D8-9E36-4F15-B192-26580BBA9490

P2860

Q36916999-0C24A4DC-02C6-4DBC-8A2A-C0CC086F351E

Q36916999-0CC07EC6-68F2-44F0-ACC8-72ED53BBD279

Q36916999-156D3454-DA1C-4232-A027-D1259EF2480D

Q36916999-1818CB4D-F7A6-4448-9F9B-FC77656728AD

Q36916999-18AEC1FB-9C7D-47D8-A26F-8F919A2E98F9

Q36916999-1DCBEDC4-A07C-4BA2-AA36-71CA55C5ED6A

Q36916999-1EB7134B-7DD6-41E5-A290-EDC5D5D08842

Q36916999-26AD0E64-FBA3-4DFD-86F7-6B1FC7DF92E8

Q36916999-284CEC72-CF14-40B3-8EF5-B8A206B28407

Q36916999-2A61B7B5-F5D0-4619-8E9E-EA6994CBD5CC

P2888

Q36916999-EF529647-0F81-4235-AA30-9ADFF303BA8A

P304

Q36916999-723D8410-D387-4A92-8BB5-CD4C7B44A000

P31

Q36916999-C7406FC9-3785-407C-BCF3-F25ACC91178D

P356

Q36916999-063E336D-6C31-47B8-AE7A-2B9D6A989679

P433

Q36916999-999B9C08-B415-4376-B4FF-FF977ACA6601

P478

Q36916999-1A79C58B-D4BA-474D-98B9-2FD6A5F300D7

P577

Q36916999-DF6B26E3-F977-453C-AF01-165751FBB05F

P6179

Q36916999-DA8BCA8F-2EA7-4CAB-B441-4E36B93E6A4B

P698

Q36916999-B6B76EFA-DD2C-48C1-9669-CDBC8854DCA8

P932

Q36916999-7A1444DB-65D9-47A3-B66B-A9FFA96BA038

P356

11634260-000000000-00000

P1433

P1476

Generic substitution of lamotr ...... ons: a cohort-crossover study.

@en

P2093

Daniel M Hartung

http://www.w3.org/2001/XMLSchema#string

Jessina C McGregor

http://www.w3.org/2001/XMLSchema#string

Leanne Svoboda

http://www.w3.org/2001/XMLSchema#string

Luke Middleton

http://www.w3.org/2001/XMLSchema#string

P2860

Comparing generic and innovator drugs: a review of 12 years of bioequivalence data from the United States Food and Drug Administration.

Should we use a case-crossover design?

Refilling and switching of antiepileptic drugs and seizure-related events

Seizure outcomes following the use of generic versus brand-name antiepileptic drugs: a systematic review and meta-analysis.

Brand spanking? The presumptive risks of generic antiepileptic drugs.

The backlash against bioequivalence and the interchangeability of brand-name and generic drugs.

A review of uses of health care utilization databases for epidemiologic research on therapeutics.

Antiepileptic drugs: generic versus branded treatments.

Clinical equivalence of generic and brand-name drugs used in cardiovascular disease: a systematic review and meta-analysis.

Generic antiepileptic drugs: current controversies and future directions

P2888

11634260-000000000-00000

P304

707-716

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2165/11634260-000000000-00000

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

26

http://www.w3.org/2001/XMLSchema#string

P577

2012-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1014288632

http://www.w3.org/2001/XMLSchema#string

P698

22731934

http://www.w3.org/2001/XMLSchema#string

P932

3677951

http://www.w3.org/2001/XMLSchema#string